Duloxetine in the treatment of major depressive disorder: A double-blind clinical trial

Journal of Clinical Psychiatry

Volumn 63, Issue 3, 2002, Pages 225-231

  Goldstein, David J ^a   Mallinckrodt, Craig ^a   Lu, Yili ^a   Demitrack, Mark A ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; DESIPRAMINE; DULOXETINE; FLUOXETINE; PLACEBO;

ADULT; ANOREXIA; ANXIETY NEUROSIS; ARTICLE; ASTHENIA; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HEADACHE; HUMAN; HYPERTENSION; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; PHASE 2 CLINICAL TRIAL; PHOBIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEXUAL DYSFUNCTION; SOMNOLENCE; VERTIGO; XEROSTOMIA;

EID: 0036112313     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v63n0309     Document Type: Article

References (31)

1. Patterns of antidepressant use and their relation to costs of care
2. The underrecognition and undertreatment of depression: What is the breadth and depth of the problem?
3. Treatment of acute depression
4. The effects of adherence to antidepressant treatment guidelines on relapse and recurrence of depression
5. Augmentation strategies in depression 2000
6. Is there room to improve monoamine-based therapies?
7. Specific serotonin and noradrenaline reuptake inhibitors (SNRIs): A review of their pharmacology, clinical efficacy and tolerability
8. Citalopram: Clinical effect profile in comparison with clomipramine. A controlled multicenter study
9. A preliminary study of the combination of fluoxetine and desipramine for rapid treatment of depression
10. Duloxetine
11. Duloxetine (LY248686): An inhibitor of serotonin and noradrenaline uptake and an antidepressant drug candidate
12. Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptors
13. LY248686, a new inhibitor of serotonin and noradrenaline uptake
14. An open-label study of duloxetine hydrochloride, a mixed serotonin and noradrenaline reuptake inhibitor, in subjects with DSM-III-R major depressive disorder
15. The Mini-International Neuropsychiatric Interview (MINI): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10
16. Development of a rating scale for primary depressive illness
17. A new depression scale designed to be sensitive to change
18. The assessment of anxiety states by rating
19. Measuring onset of antidepressant action in clinical trials: An overview of definitions and methodology
20. A comparison of the random-effects pattern mixture model with last-observation-carried-forward (LOCF) analysis in longitudinal clinical trials with dropouts
21. Type 1 error rates from mixed-effects model repeated measures compared with fixed-effects ANOVA with missing values imputed via LOCF
22. JNC-VI Criteria: The Sixth Report of the Joint National Committee on Prevention, Direction, Evaluation, and Treatment of High Blood Pressure
23. The Arizona Sexual Experience Scale (ASEX): Reliability and validity
24. Factor analysis of the Hamilton depression scale
25. Improving the assessment of severity of depressive states: A reduction of the Hamilton Depression Scale
26. Efficacy of newer medications for treating depression in primary care patients
27. High-dose fluoxetine in the treatment of depressed patients not responsive to a standard dose of fluoxetine
28. Effects of SSRIs on sexual function: A critical review